GSK malaria vaccine 257049 Vaccine for malaria

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Sep 2006: Trial registered, NCT00380393
  2. 3 Jan 2007: Trial started, NCT00380393

The trials

NCT00380393: Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.

State
Completed
Phase
Phase 2
People
894 taking part
Started
3 Jan 2007
Primary completion
15 Aug 2008
Arms
GSK257049 Group
Results
Posted on the registry
  1. 26 Sep 2006: Trial registered
  2. 3 Jan 2007: Trial started
  3. 11 Nov 2008: Trial completed
  4. 3 Jul 2018: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.